[mseebach]

I don't know if that's correct, but if it is, it's patents that make it possible for the universities and NIH to sell the right exclusively.

Since manufacturing, testing and marketing a drug is hysterically expensive, the patent seems to serve a purpose there -- even if pharma companies are more akin to specialized investment bankers than scientists.